Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Intangibles (2018 - 2020)

Collegium Pharmaceutical (COLL) has 2 years of Change in Intangibles data on record, last reported at $1.4 million in Q2 2020.

  • For Q2 2020, Change in Intangibles changed N/A year-over-year to $1.4 million; the TTM value through Dec 2020 reached $368.2 million, changed N/A, while the annual FY2020 figure was $368.2 million, N/A changed from the prior year.
  • Change in Intangibles reached $1.4 million in Q2 2020 per COLL's latest filing, down from $366.8 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at $366.8 million in Q1 2020 and bottomed at $116000.0 in Q2 2018.